Katten works in concert with the firm’s intellectual property, financial services, and healthcare specialists to support investors such as corporate venture funds, hedge funds, and family offices. The group provides assistance to a diverse range of companies, from early-stage start-ups to established unicorns, covering initial organization, seed capital, and financings, as well as M&A, liquidity events, and routine operational matters. With a keen focus on businesses at the forefront of technology-enabled innovations, the firm has represented clients such as USITF in significant investments, including a $100m investment in a Series B financing round for Colossal Biosciences and a $30m convertible note investment in Primer Technologies. Matthew Brown guides start-ups through various funding stages, recapitalizations, and exit strategies, and Jeffrey Patt brings expertise from seed capital to late-stage financings. Brown and Patt lead the practice together from Chicago.
Key clients
- Constellation Energy
- Deerfield Management
- Emalex Biosciences Inc.
- Hudson Bay Capital Management LP
- HumanCo. LLC
- LHL Strategies, Inc.
- LHM Capital
- Mediafly, Inc.
- Porsche Investments Management SA
- PSP Capital
- RLN Holdings, LLC
- Sompriya Fine Spirits
- The Range NYC LLC
- Trinity Industries, Inc
- Trust Ventures
- U.S. Innovative Technology Fund, LP
- Venrex LLP
- Worlds Enterprises, Inc.
Work highlights
- Represented Porsche Investments in multiple transactions.
- Represented USITF in a $100m investment as part of a total capital raise of $115m in a Series B financing round by Colossal Biosciences Inc.
- Represented SomPriya Fine Spirits, LLC as issuer in a $15m Series C round led by Cleveland Avenue through a unit purchase.
Practice head
The lawyer(s) leading their teams.
Matthew Brown, Jeffrey Patt